Imexhs Limited Stock: price and insider trades · Australia

Imexhs Limited belongs to the Healthcare & Pharma sector. Filings by its managers are published through ASX. Between 18 October 2025 and 18 October 2026, 5 insiders published 9 filings.

Open-market activity splits into 6 purchases totalling €153k and 3 sales totalling €576k; 5 insiders sit on the buying side and 2 insiders on the selling side. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Douglas Flynn filed the largest sale, €550k, on 7 May 2026, which represents 5.4% of the company's market value. Among those who bought: 5 senior executives.

The data flag 4 purchases as part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last insider purchase was made public on 2 June 2026, 159 days ago.

With 9 filings in twelve months, the company is more active than the median of 4 filings across the 1,605 companies we follow on the same exchange. Over the whole record (from 2026), the tally stands at 6 purchases and 3 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. This summary is built from ASX disclosures alone and does not predict where the share price will go.